Fresenius SE & Co. KGaA (FRE F) stock market data APIs
€49.7445
-0.01(-0%)
as of January 16, 2026
Try our APIs with
free plan!
Fresenius SE & Co. KGaA Financial Data Overview
Price chart is built with
Anychart
Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through Fresenius Kabi and Fresenius Helios segment. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is based in Bad Homburg vor der Höhe, Germany.
Prev. Close
49.7445
Open
49.7358
High
50.6309
Low
49.6644
52 wk Range
31.6802-51.88
Market Cap
28 263 M
P/E Ratio
24.4781
Shares Outstanding
563 M
Revenue
22 445 M
EPS
0.82
Dividends (Yield)
0.0201
Beta
0.937
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Fresenius SE & Co. KGaA data using free add-ons & libraries
Get Fresenius SE & Co. KGaA Fundamental Data
Fresenius SE & Co. KGaA Fundamental data includes:
- Net Revenue: 22 445 M
- EBITDA: 2 515 M
- Earnings Per Share: 2
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-04
- EPS/Forecast: 0.77
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Fresenius SE & Co. KGaA News
New
Fresenius Kabi, TQ Therapeutics Announce Cell Therapy Technology Agreement
Initiative Focused on Scaling Advanced Cell and Gene Therapy to Enhance Patient Access LAKE ZURICH, Ill., January 14, 2026--(BUSINESS WIRE)--Fresenius Kabi, an operating company of Fresenius, and TQ ...
What Does Fresenius SE & Co. KGaA's (ETR:FRE) Share Price Indicate?
Fresenius SE & Co. KGaA (ETR:FRE) saw a double-digit share price rise of over 10% in the past couple of months on the XTRA. The company is now trading at yearly-high levels following the recent surge ...
FMS or MASI: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical - Instruments sector might want to consider either Fresenius (FMS) or Masimo (MASI). But which of these two companies is the best option for those looking f...
Here's What's Concerning About Fresenius SE KGaA's (ETR:FRE) Returns On Capital
If you're looking at a mature business that's past the growth phase, what are some of the underlying trends that pop up? Businesses in decline often have two underlying trends, firstly, a declining re...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
